Search - tctmd.com

Displaying 781 - 800 of 1117

Sort: Relevancy | Date

News Daily News

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

Yael L. Maxwell

July 29, 2015

News Daily News

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

L.A. McKeown

July 29, 2015

News Daily News

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

L.A. McKeown

July 29, 2015

News Daily News

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

Yael L. Maxwell

July 29, 2015

News Daily News

In Medicare Population, Early Survival Benefit of EVAR Lost After 3 Years

July 23, 2015

News Daily News

En la Población de Medicare, el Beneficio Precoz sobre la Supervivencia que ofrece EVAR Desaparece a los 3 Años

July 23, 2015

News Daily News

La Anestesia General Vuelve a Implicarse en Malos Resultados con el Tratamiento Endovascular de los ACV

L.A. McKeown

July 15, 2015

News Daily News

General Anesthesia Again Implicated in Poorer Outcomes With Endovascular Stroke Therapy

L.A. McKeown

July 15, 2015

News Daily News

La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia

Todd Neale

July 13, 2015

News Daily News

FDA批准了一种具有生存优势的心力衰竭药物

Todd Neale

July 13, 2015

News Daily News

FDA Approves Heart Failure Drug That Comes With Survival Benefit

Todd Neale

July 13, 2015

News Daily News

La Terapia Puente para Pacientes con FA No Previene los Tromboembolismos y Aumenta las Hemorragias

Yael L. Maxwell

July 10, 2015

News Daily News

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Yael L. Maxwell

July 10, 2015

News Industry News

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

July 07, 2015

News Industry News

American Heart Association's New Stroke Treatment Guidelines Establish Stent Retrievers as First-Line Endovascular Treatment for Acute Ischemic Stroke

June 30, 2015

News Daily News

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

Yael L. Maxwell

June 26, 2015

News Daily News

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

Yael L. Maxwell

June 26, 2015

News Industry News

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

June 25, 2015

Advertisement

Subestudio BASKET-PROVE: Los SLF son Mejores que los SMD en Pacientes Ancianos con Arterias Grandes

La Evidencia de la Regresión de la Placa Avala el Uso Combinado de Ezetimibe+Estatinas

Evidence of Plaque Regression Bolsters Case for Combining Ezetimibe With Statin

BASKET-PROVE Substudy: DES Better Than BMS in Elderly Patients With Large Arteries

In Medicare Population, Early Survival Benefit of EVAR Lost After 3 Years

En la Población de Medicare, el Beneficio Precoz sobre la Supervivencia que ofrece EVAR Desaparece a los 3 Años

La Anestesia General Vuelve a Implicarse en Malos Resultados con el Tratamiento Endovascular de los ACV

General Anesthesia Again Implicated in Poorer Outcomes With Endovascular Stroke Therapy

La FDA Aprueba un Fármaco contra la Insuficiencia Cardíaca que Beneficia la Supervivenia

FDA批准了一种具有生存优势的心力衰竭药物

FDA Approves Heart Failure Drug That Comes With Survival Benefit

La Terapia Puente para Pacientes con FA No Previene los Tromboembolismos y Aumenta las Hemorragias

Bridging Therapy for A-fib Patients Fails to Prevent Thromboembolism, Increases Bleeding

Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan)

American Heart Association's New Stroke Treatment Guidelines Establish Stent Retrievers as First-Line Endovascular Treatment for Acute Ischemic Stroke

LEVANT 2: Un BRF Supera a la Angioplastia con Balón Estándar al cabo de 1 Año en el Manejo de la Enfermedad Femoropoplítea

LEVANT 2: DCB Beats Standard Balloon Angioplasty at 1 Year in Femoropopliteal Disease

The New England Journal of Medicine publishes LEVANT 2 results for the Lutonix® Drug Coated Balloon, showing superior efficacy compared to standard PTA

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content